Veeva Announces Expanded Partnership with Roche
Veeva Systems (NYSE: VEEV) announced that Roche Pharmaceuticals will extend its partnership by adopting Veeva Vault CRM across Roche's global pharma organization, expanding Veeva's commercial footprint.
The announcement highlights that Veeva AI — described as agentic, industry-specific AI — will power Vault CRM with four planned AI agents: Free Text Agent, Voice Agent, Pre-call Agent, and Media Agent, which are planned for availability in December 2025.
The release frames the move as enabling more personalized HCP interactions and improved insights for field teams, without disclosing financial terms or contract value.
Veeva Systems (NYSE: VEEV) ha annunciato che Roche Pharmaceuticals estenderà la propria partnership adottando Veeva Vault CRM in tutta l'organizzazione farmaceutica globale di Roche, ampliando l'impronta commerciale di Veeva.
L'annuncio sottolinea che Veeva AI — descritta come un'IA agentica, specifica per l'industria — alimenterà Vault CRM con quattro agenti IA previsti: Free Text Agent, Voice Agent, Pre-call Agent e Media Agent, che dovrebbero essere disponibili entro dicembre 2025.
La comunicazione presenta la mossa come in grado di consentire interazioni più personalizzate con gli HCP e di fornire insight migliori ai team sul campo, senza rivelare i termini finanziari o il valore del contratto.
Veeva Systems (NYSE: VEEV) anunció que Roche Pharmaceuticals ampliará su asociación adoptando Veeva Vault CRM en toda la organización farmacéutica global de Roche, expandiendo la huella comercial de Veeva.
El anuncio destaca que Veeva AI — descrita como una IA agencial, específica de la industria — impulsará Vault CRM con cuatro agentes de IA planificados: Free Text Agent, Voice Agent, Pre-call Agent y Media Agent, que se espera estén disponibles en diciembre de 2025.
El comunicado enmarca la medida como una habilitación de interacciones más personalizadas con HCP y de mejores insights para los equipos de campo, sin revelar términos financieros ni el valor del contrato.
Veeva Systems (NYSE: VEEV)은 Roche Pharmaceuticals가 파트너십을 확대하여 Roche의 글로벌 제약 조직 전체에 Veeva Vault CRM를 도입하고 Veeva의 상업적 입지를 확장할 것이라고 발표했습니다.
발표에 따르면 Veeva AI — 산업별로 특화된 에이전트형 AI로 묘사된 —가 Vault CRM을 네 가지 예정된 AI 에이전트로 구동할 것이며, Free Text Agent, Voice Agent, Pre-call Agent 및 Media Agent가 2025년 12월에 이용 가능할 예정이라고 합니다.
이번 발표는 현장 팀을 위한 더 개인화된 HCP 상호작용과 향상된 인사이트를 가능하게 하는 조치로 설명되며, 재무 조건이나 계약 가치를 공개하지 않습니다.
Veeva Systems (NYSE: VEEV) a annoncé que Roche Pharmaceuticals étendra son partenariat en adoptant Veeva Vault CRM à travers l'organisation pharmaceutique mondiale de Roche, élargissant ainsi l'empreinte commerciale de Veeva.
L'annonce souligne que Veeva AI — décrite comme une IA agentique, spécifique à l'industrie — alimentera Vault CRM avec quatre agents IA prévus : Free Text Agent, Voice Agent, Pre-call Agent et Media Agent, qui devraient être disponibles en décembre 2025.
Le communiqué présente ce mouvement comme permettant des interactions plus personnalisées avec les HCP et des insights améliorés pour les équipes sur le terrain, sans divulguer les conditions financières ni la valeur du contrat.
Veeva Systems (NYSE: VEEV) gab bekannt, dass Roche Pharmaceuticals seine Partnerschaft durch die Einführung von Veeva Vault CRM in der globalen Pharmaorganisation von Roche erweitern wird und damit Veevas kommerzielle Präsenz vergrößert.
Die Ankündigung hebt hervor, dass Veeva AI — beschrieben als agentische, branchenspezifische KI — Vault CRM mit vier geplanten KI-Agenten antreiben wird: Free Text Agent, Voice Agent, Pre-call Agent und Media Agent, die voraussichtlich im Dezember 2025 verfügbar sein werden.
Die Veröffentlichung rahmt den Schritt als Ermöglichung personalisierterer Interaktionen mit HCPs und verbesserten Einsichten für das Außenteam, ohne finanzielle Bedingungen oder Vertragswert offenzulegen.
Veeva Systems (NYSE: VEEV) أعلنت أن Roche Pharmaceuticals ستوسع شراكتها من خلال اعتماد Veeva Vault CRM عبر المنظمة الدوائية العالمية لـ Roche، مما يوسع حضور Veeva التجاري.
الإعلان يبرز أن Veeva AI — الموصوفة بأنها ذكاء اصطناعي توكيدي، خاص بالصناعة — ستشغّل Vault CRM مع أربعة وكلاء ذكاء اصطناعي مخطط لهم: Free Text Agent, Voice Agent, Pre-call Agent و Media Agent، والمتوقّع أن تتوفر في ديسمبر 2025.
الإصدار يضع هذه الخطوة في إطار تمكين تفاعلات أكثر تخصيصاً مع HCPs وتحسين الرؤى لفرق الميدان، دون الكشف عن الشروط المالية أو قيمة العقد.
- Roche to adopt Vault CRM across global pharma organization
- Veeva AI agents for Vault CRM planned for December 2025
- No financial terms disclosed for the Roche adoption
- AI agents not available until December 2025, delaying benefits
Veeva to deliver next generation customer engagement with agentic AI for Roche
"Roche and Veeva have partnered for many years," said Veeva CEO Peter Gassner. "We are honored to extend our partnership to Vault CRM and bring the next generation of AI-enabled CRM to the global Roche Pharma field teams."
"We're excited to expand our partnership with Veeva by implementing Vault CRM across our global Pharma organization," said Wafaa Mamilli, Roche's chief digital and technology officer. "With data and AI at its core, Vault CRM will help us create more personalized interactions, giving our teams the insights to better support healthcare professionals and the patients they serve."
Vault CRM is part of the Vault CRM Suite of applications that provides the foundation for commercial execution. Veeva AI is agentic AI in the Vault platform and deep, industry-specific AI agents in all Veeva applications. Veeva AI Agents for Vault CRM – Free Text Agent, Voice Agent, Pre-call Agent, and Media Agent – are planned for availability in December 2025.
About Veeva Systems
Veeva delivers the industry cloud for life sciences with software, data, and business consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Veeva Forward-Looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended October 31, 2025, which you can find here (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov.
Contact:
Maria Scurry
Veeva Systems
maria.scurry@veeva.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/veeva-announces-expanded-partnership-with-roche-302623780.html
SOURCE Veeva Systems
FAQ
What did Veeva (VEEV) announce about its partnership with Roche on November 24, 2025?
Which Veeva AI features will be added to Vault CRM and when will they be available for VEEV?
How will the Vault CRM rollout affect Roche's field teams according to Veeva (VEEV)?
Does the Veeva (VEEV) announcement disclose contract value or financial impact of the Roche deal?
Is the Roche adoption of Veeva Vault CRM final and global for VEEV?
